TY  - GEN
AU  - Claessen,Bimmer E
AU  - Beijk,Marcel A
AU  - Legrand,Victor
AU  - Ruzyllo,Witold
AU  - Manari,Antonio
AU  - Varenne,Olivier
AU  - Suttorp,Maarten J
AU  - Tijssen,Jan G P
AU  - Miquel-Hebert,Karine
AU  - Veldhof,Susan
AU  - Henriques,Jose P S
AU  - Serruys,Patrick W
AU  - Piek,Jan J
TI  - Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial
SN  - 1941-7632
PY  - 2010///0304
KW  - Aged
KW  - Angioplasty, Balloon, Coronary
KW  - adverse effects
KW  - Cardiovascular Agents
KW  - administration & dosage
KW  - Coronary Angiography
KW  - Coronary Artery Disease
KW  - diagnostic imaging
KW  - Drug-Eluting Stents
KW  - Europe
KW  - Everolimus
KW  - Female
KW  - Humans
KW  - India
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - Myocardial Ischemia
KW  - New Zealand
KW  - Paclitaxel
KW  - Prospective Studies
KW  - Single-Blind Method
KW  - Sirolimus
KW  - Thrombosis
KW  - Time Factors
KW  - Treatment Outcome
KW  - Ultrasonography, Interventional
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCINTERVENTIONS.108.831800.108.831800
ER  -